PLoS Negl Trop Dis 15(11): e0009968 Published November 15, 2021. Authors: Kimberly Y. Won, Katherine Gass, Marco Biamonte, Daniel Argaw Dagne, Camilla Ducker, Christopher
Determination, innovation and adaptation can keep lymphatic filariasis elimination on track October 21, 2021 World Health Organization COVID-19 has severely disrupted the implementation of
PLoS Negl Trop Dis 15(9): e0009596. September 20, 2021 Authors: Reza A. Niles, Charles R. Thickstun, Horace Cox, Daniel Dilliott, Clara R. Burgert-Brucker, Emma
Déclaration du Comité d’Experts de Mectizan (CEM) sur l’utilisation du Mectizan® : Le Comité rappelle à nos pays partenaires que le Mectizan® est exclusivement
A Mectizan Expert Committee (MEC) Statement on the use of Mectizan® during the COVID-19 pandemic: The MEC reminds country partners that Mectizan is donated only
International Health, Volume 13, Issue Supplement_1, January 2021, Pages S55–S59 Published December 22, 2020 Authors: Alison Krentel, Margaret Gyapong, Deborah A McFarland, Olumide Ogundahunsi,
Malawi becomes the second country in sub-Saharan Africa to eliminate lymphatic filariasis (elephantiasis) LILONGWE, MALAWI, Oct. 28, 2020 — Today the World Health Organization
This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in
A recent study informed that ivermectin was successfully used in vitro for the treatment of SARS-CoV-2 in experimentally infected cells and two preprint publications
Parasites Vectors 13, 258 (2020). Published May 15, 2020. Authors: Jérémy T Campillo, Cédric B Chesnais, Sébastien D Pion, Jacques Gardon, Joseph Kamgno, Michel
Yemen eliminates lymphatic filariasis (elephantiasis) SANA’A, YEMEN, 27 August 2019 : MSD (trade name of Merck & Co., Inc., Kenilworth, N.J., USA), GSK, and the
